170 related articles for article (PubMed ID: 35386860)
1. Epithelial-Mesenchymal Transition-Based Gene Signature and Distinct Molecular Subtypes for Predicting Clinical Outcomes in Breast Cancer.
Hou L; Hou S; Yin L; Zhao S; Li X
Int J Gen Med; 2022; 15():3497-3515. PubMed ID: 35386860
[TBL] [Abstract][Full Text] [Related]
2. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
Front Genet; 2021; 12():661306. PubMed ID: 34249086
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
4. DNA Repair-Based Gene Expression Signature and Distinct Molecular Subtypes for Prediction of Clinical Outcomes in Lung Adenocarcinoma.
Hu B; Liu D; Liu Y; Li Z
Front Med (Lausanne); 2020; 7():615981. PubMed ID: 33330576
[No Abstract] [Full Text] [Related]
5. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
6. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
Zhu G; Xia H; Tang Q; Bi F
Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.
Li D; Lin X; Chen B; Ma Z; Zeng Y; Wang H
Front Genet; 2021; 12():723802. PubMed ID: 34659346
[No Abstract] [Full Text] [Related]
8. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma.
Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M
PeerJ; 2022; 10():e12646. PubMed ID: 35116193
[TBL] [Abstract][Full Text] [Related]
9. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
Tong H; Li T; Gao S; Yin H; Cao H; He W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
[TBL] [Abstract][Full Text] [Related]
10. An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract][Full Text] [Related]
11. Systematic construction and validation of an epithelial-mesenchymal transition risk model to predict prognosis of lung adenocarcinoma.
Tang Y; Jiang Y; Qing C; Wang J; Zeng Z
Aging (Albany NY); 2020 Dec; 13(1):794-812. PubMed ID: 33340396
[TBL] [Abstract][Full Text] [Related]
12. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
13. Identification of Epithelial-Mesenchymal Transition-Related lncRNA With Prognosis and Molecular Subtypes in Clear Cell Renal Cell Carcinoma.
Zhong W; Zhang F; Huang C; Lin Y; Huang J
Front Oncol; 2020; 10():591254. PubMed ID: 33324563
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
Ding S; Sun X; Zhu L; Li Y; Chen W; Shen K
Int Immunopharmacol; 2021 Nov; 100():108122. PubMed ID: 34536743
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
17. An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer.
Zhang B; Zhao R; Wang Q; Zhang YJ; Yang L; Yuan ZJ; Yang J; Wang QJ; Yao L
Adv Ther; 2023 Oct; 40(10):4339-4357. PubMed ID: 37462865
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an epithelial-mesenchymal transition-related gene signature for predicting prognosis.
Zhou DH; Du QC; Fu Z; Wang XY; Zhou L; Wang J; Hu CK; Liu S; Li JM; Ma ML; Yu H
World J Clin Cases; 2022 Sep; 10(26):9285-9302. PubMed ID: 36159424
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
20. A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
Kong W; Mao Z; Han C; Ding Z; Yuan Q; Zhang G; Li C; Wu X; Chen J; Guo M; Hong S; Yu F; Liu R; Wang X; Zhang J
Front Pharmacol; 2022; 13():863750. PubMed ID: 35517787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
